Medical Marketing & Media10h
Novo Nordisk welcomes patients to the Ozempic Era
With semaglutide shortages in the rearview, Novo Nordisk is doubling down on marketing efforts for its GLP-1 drugs.
Clinical Advisor12h
Novo Nordisk Provides Direct-to-Patient Delivery Option for Wegovy
Novo Nordisk is providing direct-to-patient delivery of Wegovy (semaglutide) through the NovoCare Pharmacy program.
Healio12h
NovoCare Pharmacy may improve access to Wegovy, but concerns about affordability remain
Adults with obesity who have a prescription for Wegovy but do not have insurance coverage for the drug can now purchase the ...
Fierce Pharma14h
With blood and growth disorder bids panning out, Novo Nordisk plots path to rare disease leadership: exec
Still, Novo is steadfast in its goal to eventually become a leader in the space, the company’s EVP of rare disease, Ludovic ...
EL PAÍS English16h
New anti-obesity drugs already outperform Ozempic
It was the first in a series of drugs that are, for the first time, effective against obesity and can help lessen the moral ...